Menu

Search

Clearside Biomedical’s Phase 1/2 Open Label Clinical Trial of CLS-TA With and Without Eylea in Diabetic Macular Edema Presented at the American Academy of Ophthalmology 2017 Annual Meeting

Nov 13, 2017 12:30 pm UTC| Business

ALPHARETTA, Ga., Nov. 13, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced that, on...

Detailed Research: Economic Perspectives on Service Corporation, Aramark, Owens-Illinois, Tiffany, Covanta, and Red Hat– What Drives Growth in Today's Competitive Landscape

Nov 13, 2017 12:30 pm UTC| Business

NEW YORK, Nov. 13, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Service...

Strong Fourth Quarter Propels Tyson Foods to Record Year

Nov 13, 2017 12:30 pm UTC| Business

SPRINGDALE, Ark., Nov. 13, 2017 -- Tyson Foods, Inc. (NYSE:TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson®, Jimmy Dean®, Hillshire Farm®, Ball...

FTI Consulting Appoints Leslie H. Moeller as Chairman of North and South America

Nov 13, 2017 12:30 pm UTC| Business

WASHINGTON, Nov. 13, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Leslie H. Moeller as Chairman of North and South America, effective immediately. Mr. Moeller joins FTI Consulting from...

Applied Materials to Present at Upcoming Investor Conference

Nov 13, 2017 12:30 pm UTC| Business

SANTA CLARA, Calif., Nov. 13, 2017 -- Applied Materials, Inc. announced today that Dan Durn, Senior Vice President and CFO, will participate in a question-and-answer session at the Credit Suisse Annual Technology, Media...

Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results

Nov 13, 2017 12:30 pm UTC| Business

IRVING, Texas, Nov. 13, 2017 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2017,...

Development of Therapeutic Monoclonal Antibody Products 2017-2021

Nov 13, 2017 12:26 pm UTC| Business

Dublin, Nov. 13, 2017 -- The "The Development of Therapeutic Monoclonal Antibody Products" report has been added to Research and Markets' offering. As the pharmaceutical market in the United States...

  9811 9812 9813 9814 9815 9816 9817 9818 9819 9820   

Economy

Wall Street Analysts Weigh in on Latest NFP Data

Wall Street analysts are closely analyzing the latest Non-Farm Payrolls (NFP) data, which offers crucial insights into the U.S. labor market. The report revealed a robust job creation figure, exceeding economists...

Bank of America Signals End to Fed Rate Cuts Amid Robust Job Market

Bank of America (BofA) has revised its forecast, stating the Federal Reserves rate-cutting cycle has concluded. This shift follows a stronger-than-expected December jobs report, which revealed a substantial payroll...

Stocks Slide as Strong Jobs Report Sparks Fed Rate Pause Concerns

The SP 500 plunged 1.6% on Friday after a stronger-than-expected December jobs report heightened fears of a prolonged Federal Reserve rate pause. The Dow Jones dropped 707 points (1.7%), while the NASDAQ Composite also...

EU Probes Musk's X Over Talk With AfD Leader Amid Election Concerns

Elon Musks planned discussion with Alice Weidel, leader of Germanys far-right Alternative for Germany (AfD) party, on his platform X is under scrutiny by the European Commission. This comes ahead of Germanys upcoming...

BlackRock Seeks FDIC Oversight Deadline Extension to March

BlackRock, the worlds largest asset manager, is requesting an extension on the Federal Deposit Insurance Corporation (FDIC) oversight deadline to March. The move comes as the company navigates regulatory complexities tied...

Politics

Biden Calls for Enhanced Cybersecurity to Counter Escalating Threats

President Joe Biden is introducing an executive order to strengthen cybersecurity standards for federal agencies and contractors, targeting vulnerabilities exposed by recent cyberattacks linked to China. The order,...

Liberal Party Seeks Trudeau's Replacement as Leadership Race Heats Up

Canadas Liberal Party is in search of a new leader following Prime Minister Justin Trudeaus announcement to step down. The winner will be revealed on March 9. Top contenders include prominent figures with extensive...

Japan’s Foreign Minister to Attend Trump’s Inauguration

Japanese Foreign Minister Takeshi Iwaya is set to attend Donald Trumps January 20 inauguration for his second term as U.S. president, marking a historic first for a Japanese cabinet member. According to Japans Nikkei...

Biden Extends Deportation Relief for 900,000 Immigrants Ahead of Trump's Return

President Joe Bidens administration has renewed deportation protections for 900,000 immigrants from Venezuela, El Salvador, Ukraine, and Sudan through the Temporary Protected Status (TPS) program. This move extends their...

Maduro Sworn in for Controversial Third Term Amid Election Dispute

Venezuelan President Nicolas Maduro, in power since 2013, was inaugurated for a third term despite an ongoing election dispute and international backlash. The July election, declared in Maduros favor by Venezuelas...

Science

Explosive CIA Whistleblower Claims Havana Syndrome Victims Face Cancer, Dementia, and Government Betrayal

A former CIA operative has come forward with alarming allegations, claiming that victims of the mysterious Havana Syndrome are now battling devastating health issues, including cancer, dementia, and Parkinsons disease. The...

FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update

In a significant advancement for cancer care, the U.S. Food and Drug Administration (FDA) has approved an injectable version of Bristol Myers Squibbs blockbuster cancer drug Opdivo. Branded as Opdivo Qvantig, the new...

Public Health Experts Warn of ‘Quad-Demic’ as Flu, COVID, RSV, and Norovirus Threaten Winter Surge

Public health experts are raising alarms over a potential quad-demic this winter, with flu, COVID-19, respiratory syncytial virus (RSV), and norovirus all expected to surge simultaneously. This unprecedented convergence of...

Philippines' 'Missile Acquisition' Plan Provokes China's 'Arms Race' Warning

The Philippines has announced plans to acquire the U.S.-developed Typhon missile system to bolster its maritime defense capabilities. This decision has elicited strong reactions from China, which warns that such a move...

Technology

Optimistic Outlook for Chipmakers in 2025 Driven by AI Demand

Mizuho analysts project a positive 2025 for chipmakers, supported by robust artificial intelligence (AI) demand, data center expansion, and advancements in networking and memory chips. This optimism persists despite...

TSMC December Sales Surge 57.8%, Driven by AI Demand

TSMC (NYSE:TSM), the worlds leading contract chipmaker, posted a 57.8% year-on-year jump in December sales, reaching T$278.16 billion ($8.44 billion). This sharp growth highlights robust demand from the booming artificial...

Tesla Unveils Redesigned Model Y in China to Compete in Crowded EV Market

Tesla has introduced a revamped Model Y in China, aiming to recapture market share from competitors like Xiaomi. Priced at 263,500 yuan ($35,900), the updated Model Y is 5.4% more expensive than its predecessor. Deliveries...

Elon Musk Offers Starlink Aid Amid LA Wildfires, Criticizes California's Crisis Management

Elon Musk announced that SpaceX would provide free Starlink terminals to wildfire-stricken areas in Los Angeles. The Tesla CEO shared on social media platform X that the terminals would be delivered by Thursday morning to...

Elon Musk’s Controversial EU Clashes Amid DSA Investigation

Elon Musk hosting Alice Weidel, leader of Germanys far-right Alternative for Germany (AfD) party, on his X platform has drawn scrutiny from the European Commission. This move coincides with heightened EU efforts to curb...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.